Alphen aan den Rijn (September 30, 2013) - Wolters Kluwer today announced that it has completed the disposal of its French healthcare publishing activities to Galilée.
This divestiture is part of the broader Pharma divestment program originally announced in July 2011. Since that time, the pharma-related assets, including the activities sold today, have been treated as assets held for sale and have been included in discontinued operations.
The French assets included in today's disposal were part of the Legal & Regulatory portfolio and encompass healthcare magazines and journals for pharmacists, veterinarians, dentists, nurses and physicians, as well as related trade show and training activities. NewsMed - a company held by Galilée - will take on the healthcare publishing activities located in France, and Galilée takes on directly activities in the United Kingdom.
The divestment will enable Wolters Kluwer Legal & Regulatory to focus on its core legal and compliance information and software offerings.
Terms of the deal were not disclosed.
About Wolters Kluwer
Wolters Kluwer is a leading global information services and solutions company. It provides information, software, and services that help legal, tax, finance, and healthcare professionals make their most critical decisions effectively and with confidence. Customers depend on Wolters Kluwer services and solutions to successfully move through the complex layers of data and regulation that define modern business and government.
Wolters Kluwer had 2012 annual revenues of €3.6 billion. The Group employs over 19,000 people worldwide and maintains operations in over 40 counties across Europe, North America, Asia Pacific, and Latin America. The Company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
